Press Release Phanes Therapeutics Announces Expansion of Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate Spevatamig in Combination with KEYTRUDA® (Pembrolizumab) and Chemotherapy for Treatment of Biliary Tract Cancer Phanes Therapeutics, Inc. · Jul 21
Press Release HUYA Inc. to Report Second Quarter 2026 Financial Results on Tuesday, August 11, 2026 HUYA Inc. · Jul 21
Press Release BlackRock, Carhartt, Ford and Google Launch New Alliance to Expand Skilled Workforce Training CARHARTT · Jul 21
Press Release Arkenstone Defense Names OpenAI’s Joseph Larson as Lead Independent Board Director Business Wire · Jul 21
Press Release LINAK Gets Its First Measurable Marketing Return in Years with ZoomInfo Business Wire · Jul 21
Press Release AIP, MGX and BlackRock’s GIP Close Acquisition of Aligned Data Centers Business Wire · Jul 21
Press Release Jumio Accelerates the Shift to Identity Intelligence with Strong Q2 2026 Growth Business Wire · Jul 21
Press Release The Grove Foundation Finds AI Platforms Quietly Claim Ownership of How Employees Think by Expanding “Usage Data” Terms Business Wire · Jul 21